President's Message

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. | December 18, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the second COVID-19 vaccine authorized for use in the U.S.

ASGCT News   |   President's Message

Read Full Story

Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy

Stephen J. Russell, M.D., Ph.D. | December 11, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the first COVID-19 vaccine authorized for use in the U.S.

ASGCT News   |   President's Message

Read Full Story

ASGCT's Role in Treating Sickle Cell Disease

Guangping Gao, Ph.D. | September 16, 2019

September is Sickle Cell Awareness Month, and a major goal of ASGCT’s new strategic plan is to expand our outreach to countries outside the U.S.

President's Message

Read Full Story

What is the ASGCT Policy Summit?

Guangping Gao, Ph.D. | July 19, 2019

Registration is now open for the ASGCT Policy Summit as ASGCT heads back to Washington D.C. November 4 – 6. But what is it? All that and more from ASGCT President Guangping Gao, Ph.D.

Advocacy   |   President's Message

Read Full Story

The Case for Growth

Guangping Gao, Ph.D. | May 09, 2019

Following a record-breaking ASGCT Annual Meeting, the Society is ready to branch out and ensure its growth is sustainable.

Annual Meeting 2019   |   ASGCT News   |   President's Message

Read Full Story

President's Message—December 2018

Michele Calos, Ph.D. | December 13, 2018

ASGCT President Michele Calos, Ph.D. announces the opening of registration for the 22nd Annual Meeting in her latest President's Message.

President's Message

Read Full Story

President's Message—Abstracts, Value Summit, and ESGCT

Michele Calos, Ph.D. | October 09, 2018

The abstract collection is the lifeblood of ASGCT’s Annual Meeting, and the Society is excited to feature the future of our field at the Washington Hilton next year. I encourage all of you to consider submitting your research to the ASGCT Annual Meeting.

ASGCT News   |   President's Message

Read Full Story

President's Message—June 2018

Michele Calos, M.D. | June 11, 2018

Michele Calos, Ph.D. recaps the stunningly successful 21st ASGCT Annual Meeting and announces the opening of the Society's Career Development Grant program in her first address as ASGCT president.

ASGCT News   |   President's Message

Read Full Story

ASGCT President's Message—May 2018

Dr. Helen E. Heslop | May 03, 2018

Join ASGCT President Dr. Helen Heslop for her final President's Message before the 21st Annual Meeting.

President's Message

Read Full Story

ASGCT President's Message—March 2018

Dr. Helen E. Heslop | March 15, 2018

With the ASGCT Annual Meeting just two months away, we're excited to announce the ASGCT award honorees for 2018 and a reminder for members to vote before the April 10 deadline.

President's Message

Read Full Story

ASGCT President's Message—January 2018

Dr. Helen E. Heslop | January 18, 2018

Catch up with ASGCT President Dr. Helen E. Heslop on plans for the 21st Annual Meeting, the Society's plans for the new year, and the first AAV gene therapy approval in the United States.

President's Message

Read Full Story

Credit: Gage Skidmore (flickr.com)/Creative Commons 2.0

To Senator Hatch: Save the ODTC

Dr. Helen E. Heslop & Dr. Rachel Salzman | December 12, 2017

The retention of the Orphan Drug Tax Credit within the final tax bill is crucially important in providing the incentives necessary for the innovation of gene therapies for rare diseases.

ASGCT News   |   Funding   |   Policy Updates   |   President's Message

Read Full Story